Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KKfiledCriticalDainippon Pharmaceutical Co Ltd
Priority to ES511376ApriorityCriticalpatent/ES511376A0/es
Publication of ES8304150A1publicationCriticalpatent/ES8304150A1/es
Publication of ES511376A0publicationCriticalpatent/ES511376A0/es
102000004169proteins and genesHuman genes0.000title1
108090000623proteins and genesProteins0.000title1
239000000126substanceSubstances0.000title1
ES511376A1982-04-131982-04-13"un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".
GrantedES511376A0
(es)